Navigation Links
Discovering soybean plants resistant to aphids and a new aphid
Date:8/10/2009

were able to breed these genes into Midwest-adapted varieties quickly and easily," Diers said. "We can complete three crossing generations a year by using both greenhouses and fields. This year is a milestone because we now have a variety that's being commercially produced that carries the resistance gene from Dowling. This is its first commercial production of an aphid-resistant variety in the Midwest."

Unfortunately, the celebration didn't last long. While studying soybean plants, they discovered a new type of aphid. "We were excited about finding the resistance. We discovered this gene from Dowling and Jackson, bred it into varieties and we 'hoped that we could solve the aphid problem,' but of course things are never that simple," Diers said. "We found that there are different biotypes of soybean aphids, including a biotype that can overcome the resistance gene for Dowling."

In tests, this new aphid was able to infest Dowling as well as it could any susceptible genotype of soybean. "We don't know how widespread those aphids are or whether or not this is actually going to occur in fields, but certainly it's something to be concerned about because we know that resistance isn't going to be perfect," Diers said.

The good news is that the PI 200538 gene for resistance is different than the one in Dowling and Jackson. "We found that this second resistance gene in the PI protects the plants against this new biotype of aphid. We are currently breeding the PI 200538 gene into varieties, but it will be at least a few years before any varieties with this gene will be released."

Even after the appearance of this new aphid, Diers is still optimistic. "We have one variety with the Dowling resistance gene that's being commercialized this year. A company is increasing seed of a second variety with the Dowling gene that should be commercialized next year. So we'll have two varieties available to growers." He explained that the U of I aphid-re
'/>"/>

Contact: Debra Levey Larson
dlarson@illinois.edu
217-244-2880
University of Illinois at Urbana-Champaign
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Discovering drugs, biofuels in tropical seas
2. Discovering the secret code behind photosynthesis
3. Deadlines for 2007 National Soybean Rust Symposium fast approaching
4. DOE JGI releases soybean genome assembly to enable worldwide bioenergy research efforts
5. Soybean varieties viable in southern Indiana, resistant to root-knot nematode
6. Soybean grant gives researchers tools to unravel better bean
7. Tool helps identify gene function in soybeans
8. DOE Joint Genome Institute completes soybean genome
9. Soybean database will help breeders engineer better-performing plants
10. Plant soybean early to increase yield
11. No consistent advantage for planting soybean early

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...s about the health benefits of having a life partn... where amino acids known as cysteines are much mor...d up with other cysteines. , Now, researchers at... in Belgium, have discovered a new antioxidant sys...ppears in the Nov. 20 issue of the journal Scienc...
(Date:11/20/2009)...tists from the Marine Biogeochemistry and Geology ...ratory (NRL) organized and led a team of universit...n to initiate methane hydrate exploration in the B... sediment contribution to Arctic climate change. ,... as a research platform, three cross-shelf transec...
(Date:11/20/2009)...ial gene into yeast, researchers from Delft Univer...ee improvements in bioethanol production from agri...te and elimination of the major by-product glycero...ientific journal Applied and Environmental Microb...the yeast Saccharomyces cerevisiae from sugars obt...
Breaking Biology News(10 mins):Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2Delft breakthrough in bioethanol production from agricultural waste 2Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 1Ranbaxy Receives Final Approval to Manufacture and Market Glycopyrrolate Tablets 55137 2Advanced Instruments Introduces Next Generation Web Site 13665 1Advanced Instruments Introduces Next Generation Web Site 13665 2CareTech to Provide Web Services to Blessing Health System 55135 1CareTech to Provide Web Services to Blessing Health System 55135 2CareTech to Provide Web Services to Blessing Health System 55135 3CareTech to Provide Web Services to Blessing Health System 55135 4
...ter wi-fi, music over the internet, pitch percepti... favorite salmon, detecting dangerous swimmers, he...hm and movement disorders, visualizing the sound o...to save manatees from collisions with boats. , T...at the 156th meeting of the Acoustical Society of ...
...t Professor of Biomedical Engineering and Orthoped...oundation New Scholar in Aging by The Ellison Medi...s invited to nominate two faculty members to submi...ed for this award after an internal competition. N...s being granted out of 97 applicants. Dr. Alsberg ...
...screened known drugs and identified small molecule...nes, which can have dangerous side effects. This n... from fibroblasts, a general cell type that is abu...including skin. , The study was published in the ...e journal Cell Stem Cell. , "Our study shows fo...
Other Biology News:Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 2Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 3Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 4Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 5Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 6Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 7Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 8Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 9Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 10Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 11Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 12Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 13Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 14Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 15Acoustical Meeting, Nov. 10-14, 2008 in Miami, Florida 16Case Western Reserve receives Ellison Medical Foundation New Scholar in Aging award 2Scripps research scientists identify compounds for stem-cell production from adult cells 2Scripps research scientists identify compounds for stem-cell production from adult cells 3
(Date:11/20/2009).... 20 Veridiam (www.veridiam.com) w...ompany category at the 2009 Workplace Excellence A...ociety for Human Resources Management and recogniz...ices. ,, Veridiam was one of nine winners, sele...es, honored at the recent awards ceremony. San Die...
(Date:11/20/2009)...OLM, November 20 Karolinska Develo...ent Fund (EIF) has entered into a,co-investment ag...ill be,managed by Karolinska Development and used ...e pharmaceutical and medical technology companies....nvestment fund. The agreement,represents EIF,s lar...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domini...he Role of Process Analytical Technology (PAT) in ...cember 1, 2009. , (PRWEB)...ess Analytical Technology (PAT) in Green Chemistry...cess Analytical Technology (PAT) case studies will...
(Date:11/19/2009)...19 Omeros Corporation (N... results for the third quarter ended September 30,...09, Omeros reported a net loss of $3.9 million, or...4 million, or $2.54 per share, for the same period...2009, the Company reported a net loss of $15.5 mil...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8
...-Guided IMRT to Spare Healthy .... 16 Doctors at cancer,treatment centers in the U...head and neck cancer using RapidArc(TM) radiothera...VAR ). RapidArc was used to deliver ultra-precise,...T) significantly faster,than was previously possib...
...uticals, Inc. (Nasdaq: BCRX ) today announced tha...resident of BioCryst, will present,a corporate upd...e in New,York on Tuesday, September 23, 2008 at 2:... cast of the presentation may be accessed on,the B...esentation will be,archived for 30 days., About B...
... MIGENIX Inc. (the,"Company" or "MIGENIX") (TSX: M...gs for infectious diseases, reports financial resu...rovides a corporate update on its programs,and oth... Omiganan 1% gel (Omigard(TM)/CPI-226/MX-226; top...ted infections): Cadence Pharmaceuticals, Inc.,("C...
Other Biology Technology:Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck 2Doctors in the US and Netherlands Using Fast RapidArc Radiotherapy Technology to Help Fight Cancer are Now Treating Tumors of the Head and Neck 3BioCryst to Present at UBS 2008 Global Life Sciences Conference 2BioCryst to Present at UBS 2008 Global Life Sciences Conference 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 2MIGENIX Reports First Quarter Fiscal 2009 Financial Results 3MIGENIX Reports First Quarter Fiscal 2009 Financial Results 4MIGENIX Reports First Quarter Fiscal 2009 Financial Results 5MIGENIX Reports First Quarter Fiscal 2009 Financial Results 6MIGENIX Reports First Quarter Fiscal 2009 Financial Results 7MIGENIX Reports First Quarter Fiscal 2009 Financial Results 8MIGENIX Reports First Quarter Fiscal 2009 Financial Results 9MIGENIX Reports First Quarter Fiscal 2009 Financial Results 10MIGENIX Reports First Quarter Fiscal 2009 Financial Results 11
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Biology Products: